Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children

Akinobu Matsuzaki1, Aiko Suminoe, Yuhki Koga

  • 1Division of Child Health, School of Health Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. matsuzaki@shs.kyushu-u.ac.jp

Insights

Peripherally inserted central venous catheters (PICCs) are feasible for children with cancer, offering reliable access for treatment. However, long-term use increases the risk of complications like occlusion and infection.

Area of Science:

  • Pediatric Oncology
  • Vascular Access Devices
  • Medical Complications

Background:

  • Peripherally inserted central venous catheters (PICCs) are increasingly used in pediatric oncology.
  • Limited data exists on PICC complications in children with cancer.

Purpose of the Study:

  • Assess the feasibility of PICC placement in pediatric cancer patients.
  • Identify risk factors for PICC-related complications in this population.

Main Methods:

  • Retrospective evaluation of 53 pediatric patients with malignancies undergoing PICC placement.
  • Analysis of catheter dwell time, insertion details, and complication rates.
  • Inclusion of factors like patient demographics, diagnosis, and treatment type.

Main Results:

  • Successful PICC placement in 97.3% of attempts.
  • A complication rate of 4.66 per 1,000 catheter days, with 50.5% of PICCs removed due to complications.
  • Common complications included occlusion (18), breakage/leakage (15), and infection (10); over 70% occurred after 30 days.
  • Superior vena cava or right atrium tip location may reduce complication risk.

Conclusions:

  • PICCs provide reliable, prolonged vascular access for pediatric cancer patients, reducing pain and stress.
  • Long-term PICC use is associated with an increased risk of complications.
Abstract